603590 康辰藥業
按盤價 
29.370 +0.290 (+0.997%) | 2023/09 - 九個月 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.906 | 3.491 | 4.960 | 6.316 | 10.217 |
| 總資產報酬率 ROA (%) | 4.128 | 2.987 | 4.135 | 5.269 | 8.732 |
| 投入資產回報率 ROIC (%) | 4.727 | 3.426 | 4.828 | 6.134 | 9.947 | 邊際利潤分析 |
| 銷售毛利率 (%) | 89.830 | 85.444 | 86.940 | 92.673 | 94.590 |
| 營業利潤率 (%) | 26.183 | 16.234 | 23.746 | 25.997 | 28.099 |
| 息稅前利潤/營業總收入 (%) | 24.546 | 14.129 | 20.433 | 19.767 | 22.218 |
| 淨利潤/營業總收入 (%) | 22.615 | 14.295 | 20.677 | 22.674 | 24.962 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.167 | 99.259 | 72.601 | 75.534 | 89.247 |
| 價值變動淨收益/利潤總額(%) | 4.869 | -5.450 | 18.873 | 6.099 | 2.980 |
| 營業外收支淨額/利潤總額(%) | -0.400 | -0.276 | -1.820 | -1.057 | -0.140 | 償債能力分析 |
| 流動比率 (X) | 5.073 | 5.899 | 6.124 | 3.039 | 6.357 |
| 速動比率 (X) | 4.893 | 5.684 | 5.820 | 2.982 | 6.314 |
| 資產負債率 (%) | 9.625 | 6.852 | 7.141 | 18.536 | 14.047 |
| 帶息債務/全部投入資本 (%) | 3.551 | -0.584 | -0.715 | -0.280 | -1.488 |
| 股東權益/帶息債務 (%) | 2,658.880 | -16,868.760 | -13,673.838 | -34,575.586 | -6,544.772 |
| 股東權益/負債合計 (%) | 862.104 | 1,246.789 | 1,199.940 | 438.682 | 611.872 |
| 利息保障倍數 (X) | -16.019 | -6.856 | -7.073 | -3.318 | -3.803 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 107.194 | 106.064 | 90.845 | 86.988 | 73.492 |
| 存貨周轉天數 (天) | 150.216 | 119.869 | 137.797 | 146.421 | 74.540 |
| 備註： | 即時報價更新時間為 24/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
